Intervention Review

Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults

  1. Xavier Castells1,*,
  2. Josep Antoni Ramos-Quiroga2,
  3. Rosa Bosch2,
  4. Mariana Nogueira2,
  5. Miguel Casas2

Editorial Group: Cochrane Developmental, Psychosocial and Learning Problems Group

Published Online: 15 JUN 2011

Assessed as up-to-date: 23 AUG 2010

DOI: 10.1002/14651858.CD007813.pub2


How to Cite

Castells X, Ramos-Quiroga JA, Bosch R, Nogueira M, Casas M. Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults. Cochrane Database of Systematic Reviews 2011, Issue 6. Art. No.: CD007813. DOI: 10.1002/14651858.CD007813.pub2.

Author Information

  1. 1

    Faculty of Medicine, Universitat de Girona, Unit of Clinical Pharmacology, Department of Medical Sciences, Girona, Catalonia, Spain

  2. 2

    Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Department of Psychiatry, Barcelona, Catalonia, Spain

*Xavier Castells, Unit of Clinical Pharmacology, Department of Medical Sciences, Faculty of Medicine, Universitat de Girona, Girona, Catalonia, Spain. xavier.castells@udg.edu.

Publication History

  1. Publication Status: New
  2. Published Online: 15 JUN 2011

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    R. Cunill, X. Castells, A. Tobias, D. Capellà, Reply to the letter to the editor by Ramos-Quiroga et al., Pharmacoepidemiology and Drug Safety, 2014, 23, 4
  2. 2
    Ruth Cunill, Xavier Castells, Aurelio Tobias, Dolors Capellà, Atomoxetine for attention deficit hyperactivity disorder in the adulthood: a meta-analysis and meta-regression, Pharmacoepidemiology and Drug Safety, 2013, 22, 9
  3. 3
    Michael Venables, Evangelia Ntzani, Yingfen Hsia, Donna Gillies, Alpha2 adrenergic agonists for attention deficit hyperactivity disorder (ADHD), The Cochrane Library,
  4. 4
    Salima Punja, Larissa Shamseer, Lisa Hartling, Liana Urichuk, Ben Vandermeer, Jane Nikles, Sunita Vohra, Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents, The Cochrane Library,
  5. 5
    Salima Punja, Larissa Shamseer, Lisa Hartling, Liana Urichuk, Ben Vandermeer, Catherine J Nikles, Sunita Vohra, Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents, The Cochrane Library,
  6. 6
    Toni Redman, Elly Scheermeyer, Makoto Ogawa, Eddie C Sparks, Jeremy C Taylor, Vi T Tran, Nancy Sturman, Mieke L van Driel, Methylphenidate for core and ADHD-like symptoms in children aged 6 to 18 years with autism spectrum disorders (ASDs), The Cochrane Library,